Vivio®
By Ventric Health

Test in minutes. Results even faster.

The Vivio® System is the only accurate non-invasive approach to heart failure diagnosis available in the primary care setting.

The only non-invasive solution for measuring elevated LVEDP – the clinical hallmark of heart failure.

The complete Vivio System kit by Ventric Health, featuring portable hardware and a carrying case for mobile heart failure diagnosis.

Vivio is the only FDA-cleared Class II medical device that enables clinicians to non-invasively measure left ventricular end-diastolic pressure (LVEDP) – the clinical hallmark of heart failure. Once Vivio identifies elevated LVEDP, the system prompts the use of the Kansas City Cardiomyopathy Questionnaire 12 (KCCQ-12) to identify patient symptoms and quantify disease burden.

Approximately 70% of patients identified by Vivio with elevated LVEDP exhibit signs and symptoms on the KCCQ-12 consistent with Stage C heart failure while 30% are consistent with Stage B heart failure.1

Delivering real-time, point-of-care results, Vivio helps clinicians identify patients with heart failure earlier and initiate guideline-directed medical therapy (GDMT) in a more timely manner.

Changing the Timeline of Heart Failure Diagnosis

Vivio has superior specificity and sensitivity to clinical indications of heart failure thanks to its ability to identify elevated left ventricle filling pressures (i.e., LVEDP).2,3 This increased sensitivity and specificity allows clinicians to definitively identify patients earlier and with more confidence.

Explore the Evidence Behind Vivio:

Peer-reviewed validation studies, multicenter screening trials, and independent clinical recognition demonstrating Vivio’s performance reliably at scale, in real-world primary care and population-health settings.

Clinician applying the Vivio System arm cuff to a patient to begin a non-invasive heart failure diagnostic exam.

Heart failure is hard to diagnose, and too often, it’s diagnosed too late.

Symptoms progress gradually. Patients may not recognize the warning signs, and clinicians have limited time and tools to detect changes early. As a result, many patients fall through the cracks and are first diagnosed only after their quality of life has already declined when they show up in the ER or are admitted to the hospital.4,5

At Ventric Health, we are closing that gap. We provide clinicians with unprecedented, non-invasive cardiovascular data that enables earlier identification of heart failure, so care teams can act sooner, intervene more effectively and help patients spend more healthy days at home.

That’s why we exist: to expand access to non-invasive cardiovascular testing and be the change that changes heart health.

The path to positively impacting cardiovascular health is through clinicians at the point of care.

Cardiovascular diseases are the leading cause of death in the U.S. and, despite advances in cardiovascular care, the gap in diagnosing the growing risk of heart disease remains.6 In our most vulnerable populations, symptoms are overlooked and diagnostic processes are frequently inconclusive or worse, invasive and costly, leading to poor patient outcomes.4

Precision across care models: the Vivio System enables non-invasive diagnosis of at-risk patients in the primary care setting in the earliest stages of heart failure by identifying elevated left ventricular end-diastolic pressure (LVEDP). Clinicians can perform tests in under five minutes and receive results in real time.

Primary Care Physicians

Cardiologists

Medicare ACOs

Healthcare Systems

Medicare Practice

Medicare Advantage

Trusted By Leading Health Systems Across the Country

Agilon Health - Health System Partner
AltaMed - Health System Partner
Desert Oasis Healthcare - Health System Partner
Heritage Victor Valley Medical Group - Health System Partner
Regal Medical Group - Health System Partner

Expert Perspectives

“Since adopting the Vivio System in March 2024, we’ve been able to identify changes in heart function earlier and initiate treatment sooner. It has become a valued part of our primary care strategy and allows us to have a more engaging connection with our patients while putting the focus on total-person care. Our patients and primary care physicians appreciate the proactive approach.”

Leah Dixson, PA-C, Desert Oasis Healthcare, Palm Springs CA

“One of the greatest opportunities in heart failure is recognizing the disease earlier, so more patients can benefit from treatments that can change the course of their disease. Earlier diagnosis opens the door to earlier intervention, when it can make the biggest difference in a patient’s quality of life.”

Dr. Karthik Rao, Chief Medical Officer, agilon health

“We are proud of the role our technology is playing in practices across the country to make early heart failure diagnosis more accessible, leading to improved patient outcomes and greater clinician satisfaction. Through earlier disease identification, we are helping the healthcare system better control the high and growing costs of heart failure.”

Dr. Thomas Cheek, Chief Medical Officer, Ventric Health

“Caring for our senior patients is at the heart of our mission. Because our clinics serve a broad geographic region, bringing the Vivio system directly into our primary care settings allows us to diagnose Heart Failure before patients are expressing symptoms and take action to support treatment without delay. Using Vivio is fast and easy, and having the KCCQ built-in ensures we capture the patient’s symptoms more objectively and consistently.”

Wendy Rissinger, MD, Family Practice Center, Herndon PA

RESOURCES HUB

VALIDATION

FAQs